Skip to main navigation Skip to search Skip to main content

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

  • Nancy L Bartlett
  • , Robert Chen
  • , Michelle A Fanale
  • , Pauline Brice
  • , Ajay Gopal
  • , Scott E Smith
  • , Ranjana Advani
  • , Jeffrey V Matous
  • , Radhakrishnan Ramchandren
  • , Joseph D Rosenblatt
  • , Dirk Huebner
  • , Pamela Levine
  • , Laurie Grove
  • , Andres Forero-Torres
  • Washington University School of Medicine in St. Louis
  • City of Hope
  • University of Texas Health Science Center at Houston
  • Hospital Saint-Louis
  • University of Washington - Seattle Campus
  • Loyola University Chicago
  • Stanford University
  • Colorado Blood Cancer Institute
  • Karmanos Cancer Institute
  • University of Miami
  • Takeda Pharmaceuticals International Company
  • Seattle Genetics, Inc.
  • University of Alabama - Birmingham

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalOpen Access Publications
Volume7
StatePublished - Jan 1 2014
Externally publishedYes

Cite this